Introduction: Several CSF biomarkers of neuronal injury have been studied in people living
with HIV. At this time, the most useful is the light subunit of the neurofilament protein (NFL) …

Treatment of HIV‐infected patients with highly active antiretroviral therapy (HAART) usually
results in diminished viral replication, increasing CD4+ cell counts, a reversal of most …

Background Data from randomized trials are lacking on the benefits and risks of initiating
antiretroviral therapy in patients with asymptomatic human immunodeficiency virus (HIV) …

Background Long-acting injectable antiretroviral therapy (LAI-ART) is approved for treatment-
naive or experienced people with human immunodeficiency virus (HIV; PWH) based on …

Background. We examined specific causes of mortality in human immunodeficiency virus
type 1 (HIV-1)—infected patients who initiated antiretroviral therapy (ART) in Europe and …

Objective: To investigate any emerging trends in causes of death amongst HIV-positive
individuals in the current cART era, and to investigate the factors associated with each …

Context The availability of new antiretroviral drugs and formulations, including drugs in new
classes, and recent data on treatment choices for antiretroviral-naive and-experienced …

Background The SMART study randomized 5472 human immunodeficiency virus (HIV)–
infected patients with CD4+ cell counts> 350 cells/μL to intermittent antiretroviral therapy …

Background: Little is known about the incidence and risk factors for serious non-AIDS-
defining events. Methods: The incidence of non-AIDS events (malignancies, end-stage renal …

ABSTRACT HIV infection treatment strategies have historically defined effectiveness through
measuring patient plasma HIV RNA. While combined antiretroviral therapy (cART) can …